The Potential of Fungi in the Development of Future Anti-Seizure Medications

REVIEW
Rosa de Lima Renita Sanyasi

 
For citation: Sanyasi RDLR. The Potential of Fungi in the Development of Future Anti-Seizure Medications. International Journal of Biomedicine. 2025;15(1):45-50. doi:10.21103/Article15(1)_RA6
 
Originally published March 5, 2025

Abstract: 

Background: While a significant number of epilepsy patients respond well to anti-seizure medications (ASMs), some individuals experience persistent seizures despite undergoing ASM polytherapy, a condition known as drug-resistant epilepsy (DRE). There is a pressing need for the discovery and development of new ASMs to serve as alternative and adjunct therapies for patients with DRE. Fungi are organisms that possess a wealth of anti-inflammatory and antioxidant properties, with some demonstrating neuroprotective effects. Further research and development may position mushrooms as a promising future treatment for seizure management.
Topics: The pathophysiology of epilepsy is closely linked to neuroinflammation and oxidative stress. Mushrooms exhibit potent anti-inflammatory and antioxidant properties, and several species have been investigated for their potential in epilepsy treatment. Notable mushrooms include Armillaria mellea, Amauroderma rugosum, Auricularia polytricha, Cordyceps militaris, Ganoderma lucidum, Ganoderma neo-japonicum, Hericium erinaceus, Amanita muscaria, and Pleurotus ostreatus. Additional mechanisms through which these fungi may benefit epilepsy patients include enhancing the integrity of the blood-brain barrier, reducing neuronal excitation while promoting inhibition, protecting mitochondrial function, and increasing the expression of vascular endothelial growth factor.
Conclusion: Mushrooms hold significant potential as both alternative and adjunct therapies for epilepsy. Their rich anti-inflammatory and antioxidant content is crucial in reducing seizure frequency, mitigating the progression of epilepsy, and improving patients' overall quality of life.

Keywords: 
fungus • seizures • epilepsy • anti-seizure medication
References: 
  1. Gajate-García V, Gutiérrez-Viedma Á, Romeral-Jiménez M, Serrano-García I, Parejo-Carbonell B, Montalvo-Moraleda T, Valls-Carbó A, García-Morales I. Seizures in the Emergency Department: clinical and diagnostic data from a series of 153 patients. Neurologia (Engl Ed). 2023 Jan-Feb;38(1):29-34. doi: 10.1016/j.nrleng.2020.02.011. Epub 2021 Nov 23. PMID: 34836845.
  2. Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, Engel J Jr, Forsgren L, French JA, Glynn M, Hesdorffer DC, Lee BI, Mathern GW, Moshé SL, Perucca E, Scheffer IE, Tomson T, Watanabe M, Wiebe S. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014 Apr;55(4):475-82. doi: 10.1111/epi.12550. Epub 2014 Apr 14. PMID: 24730690.
  3. Guery D, Rheims S. Clinical Management of Drug Resistant Epilepsy: A Review on Current Strategies. Neuropsychiatr Dis Treat. 2021 Jul 12;17:2229-2242. doi: 10.2147/NDT.S256699. PMID: 34285484; PMCID: PMC8286073.
  4. Siddiqui F, Soomro BA, Rehman EU, Numan A, Bano S, Salam JU, Brohi H, Zaheer M, Memon FH, Qureshi MW, Sheikh JA, Sunejo AL, Iqbal A, Abbass S, Zaidi S, Nawaz S, Fatima K, Altaf S, Maheshwary N, Khan MA, Ahmed A, Asif MI. A prospective, observational, multicentre study to evaluate the efficacy of brivaracetam as adjuvant therapy for epilepsy: The Bravo study. Drugs Context. 2024 Jul 8;13:2024-3-2. doi: 10.7573/dic.2024-3-2. PMID: 38989131; PMCID: PMC11235182.
  5. Klein P, Kaminski RM, Koepp M, Löscher W. New epilepsy therapies in development. Nat Rev Drug Discov. 2024 Sep;23(9):682-708. doi: 10.1038/s41573-024-00981-w. Epub 2024 Jul 22. PMID: 39039153.
  6. Lakshmikanthcharan S, Hisham M, Chaitanya Juluri SK, Nandakumar SM. Verapamil as an Adjuvant Treatment for Drug-Resistant Epilepsy. Indian J Crit Care Med. 2018 Sep;22(9):680-682. doi: 10.4103/ijccm.IJCCM_250_18. PMID: 30294138; PMCID: PMC6161577.
  7. Löscher W, Potschka H, Sisodiya SM, Vezzani A. Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options. Pharmacol Rev. 2020 Jul;72(3):606-638. doi: 10.1124/pr.120.019539. PMID: 32540959; PMCID: PMC7300324.
  8. Nadar RM, Pathak S, Deruiter J, Alghenaim F, Ramesh S, Lynn G, et al. “Mycotherapy (medicinal mushrooms) as a potential treatment for epilepsy” in Mushrooms with therapeutic potentials. Singapore: Springer Nature Singapore Pte Ltd. 2023:459–473.
  9. Chen X, Liu Y, Ren L, Dai X, Zhao J, Gao C, Zhang S, Dong J, Zhao Z, Li Y, Wang J, Zhao H, Gong G, He X, Bian Y. Extraction, purification, structural characteristics and biological properties of the polysaccharides from Armillaria mellea (Vahl) P. Kumm.: A review. Int J Biol Macromol. 2024 Feb;259(Pt 1):129175. doi: 10.1016/j.ijbiomac.2023.129175. Epub 2024 Jan 3. PMID: 38181916.
  10. Muszyńska B, Sułkowska-Ziaja K, Wołkowska M, Ekiert H. Chemical, pharmacological, and biological characterization of the culinary-medicinal honey mushroom, Armillaria mellea (Vahl) P. Kumm. (Agaricomycetideae): a review. Int J Med Mushrooms. 2011;13(2):167-75. doi: 10.1615/intjmedmushr.v13.i2.90. PMID: 22135893.
  11. Li Q, Li Y, Niu H, Wang E, Jiao L, Li H, et al. Structure Elucidation and Immunoactivity Study of Armillaria mellea Fruiting Body Polysaccharides.  Separations. 2024; 11(1):3.
  12. Zhang S, Liu X, Yan L, Zhang Q, Zhu J, Huang N, Wang Z. Chemical compositions and antioxidant activities of polysaccharides from the sporophores and cultured products of Armillaria mellea. Molecules. 2015 Mar 31;20(4):5680-97. doi: 10.3390/molecules20045680. PMID: 25838171; PMCID: PMC6272248.
  13. Gao LW, Li WY, Zhao YL, Wang JW. The cultivation, bioactive components and pharmacological effects of Armillaria mellea. African Journal of Biotechnology. 2009;8(25):7383-7390.
  14. Li H, Xu G, Yuan G. Effects of an Armillaria mellea Polysaccharide on Learning and Memory of D-Galactose-Induced Aging Mice. Front Pharmacol. 2022 Jul 18;13:919920. doi: 10.3389/fphar.2022.919920. PMID: 35924065; PMCID: PMC9341523.
  15. Lin YE, Wang HL, Lu KH, Huang YJ, Panyod S, Liu WT, Yang SH, Chen MH, Lu YS, Sheen LY. Water extract of Armillaria mellea (Vahl) P. Kumm. Alleviates the depression-like behaviors in acute- and chronic mild stress-induced rodent models via anti-inflammatory action. J Ethnopharmacol. 2021 Jan 30;265:113395. doi: 10.1016/j.jep.2020.113395. Epub 2020 Sep 19. PMID: 32956757.
  16. An S, Lu W, Zhang Y, Yuan Q, Wang D. Pharmacological Basis for Use of Armillaria mellea Polysaccharides in Alzheimer's Disease: Antiapoptosis and Antioxidation. Oxid Med Cell Longev. 2017;2017:4184562. doi: 10.1155/2017/4184562. Epub 2017 Sep 10. PMID: 29081887; PMCID: PMC5610814.
  17. Zheng CW, Cheung TM, Leung GP. A review of the phytochemical and pharmacological properties of Amauroderma rugosum. Kaohsiung J Med Sci. 2022 Jun;38(6):509-516. doi: 10.1002/kjm2.12554. Epub 2022 May 12. PMID: 35548873.
  18. Hapuarachchi KK, Karunarathna SC, Phengsintham P, Kakumyan P, Hyde KD, Wen TC. Amauroderma (Ganodermataceae, Polyporales) – bioactive compounds, beneficial properties and two new records from Laos. Asian Journal of Mycology. 2018;1(1):121–136.
  19. Chan PM, Kanagasabapathy G, Tan YS, Sabaratnam V, Kuppusamy UR. Amauroderma rugosum (Blume & T. Nees) Torrend: Nutritional Composition and Antioxidant and Potential Anti-Inflammatory Properties. Evid Based Complement Alternat Med. 2013;2013:304713. doi: 10.1155/2013/304713. Epub 2013 Nov 25. PMID: 24371454; PMCID: PMC3859164.
  20. Yang N, Guan QW, Chen FH, Xia QX, Yin XX, Zhou HH, Mao XY. Antioxidants Targeting Mitochondrial Oxidative Stress: Promising Neuroprotectants for Epilepsy. Oxid Med Cell Longev. 2020 Nov 25;2020:6687185. doi: 10.1155/2020/6687185. PMID: 33299529; PMCID: PMC7710440.
  21. Khatua S, Sett S, Acharya K. Auricularia spp.: from Farm to Pharmacy in “Biology, Cultivation and Application of Mushroom.” Singapore: Springer Nature. 2022:301–346.
  22. Green JL, Dos Santos WF, Fontana ACK. Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development. Biochem Pharmacol. 2021 Nov;193:114786. doi: 10.1016/j.bcp.2021.114786. Epub 2021 Sep 24. PMID: 34571003; PMCID: PMC8605998.
  23. Sillapachaiyaporn C, Rangsinth P, Nilkhet S, Ung AT, Chuchawankul S, Tencomnao T. Neuroprotective Effects against Glutamate-Induced HT-22 Hippocampal Cell Damage and Caenorhabditis elegans Lifespan/Healthspan Enhancing Activity of Auricularia polytricha Mushroom Extracts. Pharmaceuticals (Basel). 2021 Sep 29;14(10):1001. doi: 10.3390/ph14101001. PMID: 34681226; PMCID: PMC8539790.
  24. Gupta G, Pathak S, Dahiya R, Awasthi R, Mishra A, Sharma RK, Agrawal M, Dua K. Aqueous Extract of Wood Ear Mushroom, Auricularia polytricha (Agaricomycetes), Demonstrated Antiepileptic Activity against Seizure Induced by Maximal Electroshock and Isoniazid in Experimental Animals. Int J Med Mushrooms. 2019;21(1):29-35. doi: 10.1615/IntJMedMushrooms.2018029113. PMID: 30806253.
  25. Zhang XM, Tang DX, Li QQ, Wang YB, Xu ZH, Li WJ, Yu H. Complex microbial communities inhabiting natural Cordyceps militaris and the habitat soil and their predicted functions. Antonie Van Leeuwenhoek. 2021 Apr;114(4):465-477. doi: 10.1007/s10482-021-01534-6. Epub 2021 Feb 27. PMID: 33638738.
  26. Lin BQ, Li SP. Cordyceps as an Herbal Drug. In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 5. PMID: 22593927.
  27. Kim YO, Kim HJ, Abu-Taweel GM, Oh J, Sung GH. Neuroprotective and therapeutic effect of Cordyceps militaris on ischemia-induced neuronal death and cognitive impairments. Saudi J Biol Sci. 2019 Nov;26(7):1352-1357. doi: 10.1016/j.sjbs.2018.08.011. Epub 2018 Aug 17. PMID: 31762595; PMCID: PMC6864366.
  28. Lin YE, Chen YC, Lu KH, Huang YJ, Panyod S, Liu WT, Yang SH, Lu YS, Chen MH, Sheen LY. Antidepressant-like effects of water extract of Cordyceps militaris (Linn.) Link by modulation of ROCK2/PTEN/Akt signaling in an unpredictable chronic mild stress-induced animal model. J Ethnopharmacol. 2021 Aug 10;276:114194. doi: 10.1016/j.jep.2021.114194. Epub 2021 May 8. PMID: 33974945.
  29. Hsu CH, Sun HL, Sheu JN, Ku MS, Hu CM, Chan Y, Lue KH. Effects of the immunomodulatory agent Cordyceps militaris on airway inflammation in a mouse asthma model. Pediatr Neonatol. 2008 Oct;49(5):171-8. doi: 10.1016/S1875-9572(09)60004-8. PMID: 19133568.
  30. Oh JY, Choi WS, Lee CH, Park HJ. The ethyl acetate extract of Cordyceps militaris inhibits IgE-mediated allergic responses in mast cells and passive cutaneous anaphylaxis reaction in mice. J Ethnopharmacol. 2011 May 17;135(2):422-9. doi: 10.1016/j.jep.2011.03.030. Epub 2011 Mar 21. PMID: 21420483.
  31. Wu S, Zhang S, Peng B, Tan D, Wu M, Wei J, et al. Ganoderma lucidum: a comprehensive review of phytochemistry, efficacy, safety and clinical study. Food Science and Human Wellness, 2024;13(2):568-596.
  32. Ahmad MF, A Alsayegh A, Ahmad FA, Akhtar MS, Alavudeen SS, Bantun F, Wahab S, Ahmed A, Ali M, Elbendary EY, Raposo A, Kambal N, H Abdelrahman M. Ganoderma lucidum: Insight into antimicrobial and antioxidant properties with development of secondary metabolites. Heliyon. 2024 Feb 4;10(3):e25607. doi: 10.1016/j.heliyon.2024.e25607. PMID: 38356540; PMCID: PMC10865332.
  33. Wang GH, Li X, Cao WH, Li J, Wang LH. A retrospective study of Ganoderma Lucidum Spore Powder for patients with epilepsy. Medicine (Baltimore). 2018 Jun;97(23):e10941. doi: 10.1097/MD.0000000000010941. PMID: 29879039; PMCID: PMC5999473.
  34. Socala K, Nieoczym D, Grzywnowicz K, Stefaniuk D, Wlaz P. Evaluation of Anticonvulsant, Antidepressant-, and Anxiolytic-like Effects of an Aqueous Extract from Cultured Mycelia of the Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Higher Basidiomycetes) in Mice. Int J Med Mushrooms. 2015;17(3):209-18. doi: 10.1615/intjmedmushrooms.v17.i3.10. PMID: 25954905.
  35. Lau MF, Phan CW, Sabaratnam V, Kuppusamy UR. Bibliometric, taxonomic, and medicinal perspectives of Ganoderma neo-japonicum Imazeki: A mini review. Mycology. 2024 Jan 21;15(3):360-373. doi: 10.1080/21501203.2024.2302028. PMID: 39247898; PMCID: PMC11376291.
  36. Tan WC, Kuppusamy UR, Phan CW, Tan YS, Raman J, Anuar AM, Sabaratnam V. Ganoderma neo-japonicum Imazeki revisited: Domestication study and antioxidant properties of its basidiocarps and mycelia. Sci Rep. 2015 Jul 27;5:12515. doi: 10.1038/srep12515. PMID: 26213331; PMCID: PMC4515590.
  37. Qiu Y, Lin G, Liu W, Zhang F, Linhardt RJ, Wang X, et al. Bioactive substances in Hericium erinaceus and their biological properties: a review. Food Science and Human Wellness. 2024;13(4):1825-1844.
  38. Roda E, Priori EC, Ratto D, De Luca F, Di Iorio C, Angelone P, Locatelli CA, Desiderio A, Goppa L, Savino E, Bottone MG, Rossi P. Neuroprotective Metabolites of Hericium erinaceus Promote Neuro-Healthy Aging. Int J Mol Sci. 2021 Jun 15;22(12):6379. doi: 10.3390/ijms22126379. PMID: 34203691; PMCID: PMC8232141.
  39. Jang HJ, Kim JE, Jeong KH, Lim SC, Kim SY, Cho KO. The Neuroprotective Effect of Hericium erinaceus Extracts in Mouse Hippocampus after Pilocarpine-Induced Status Epilepticus. Int J Mol Sci. 2019 Feb 16;20(4):859. doi: 10.3390/ijms20040859. PMID: 30781501; PMCID: PMC6413080.
  40. Szućko-Kociuba I, Trzeciak-Ryczek A, Kupnicka P, Chlubek D. Neurotrophic and Neuroprotective Effects of Hericium erinaceus. Int J Mol Sci. 2023 Nov 3;24(21):15960. doi: 10.3390/ijms242115960. PMID: 37958943; PMCID: PMC10650066.
  41. Carboué Q, Lopez M. Amanita muscaria: Ecology, Chemistry, Myths. Encyclopedia. 2021;1:905–914.
  42. Johnston GA. Muscimol as an ionotropic GABA receptor agonist. Neurochem Res. 2014 Oct;39(10):1942-7. doi: 10.1007/s11064-014-1245-y. Epub 2014 Jan 29. PMID: 24473816.
  43. Heiss JD, Argersinger DP, Theodore WH, Butman JA, Sato S, Khan OI. Convection-Enhanced Delivery of Muscimol in Patients with Drug-Resistant Epilepsy. Neurosurgery. 2019 Jul 1;85(1):E4-E15. doi: 10.1093/neuros/nyy480. PMID: 30407567; PMCID: PMC6704347.
  44. Gernert M, MacKeigan D, Deking L, Kaczmarek E, Feja M. Acute and chronic convection-enhanced muscimol delivery into the rat subthalamic nucleus induces antiseizure effects associated with high responder rates. Epilepsy Res. 2023 Feb;190:107097. doi: 10.1016/j.eplepsyres.2023.107097. Epub 2023 Jan 25. PMID: 36736200.
  45. El-Ramady H, Abdalla N, Fawzy Z, Badgar K, Llanaj X, Törős G, Hajdú P, Eid Y, Prokisch J. Green Biotechnology of Oyster Mushroom (Pleurotus ostreatus L.): A Sustainable Strategy for Myco-Remediation and Bio-Fermentation. Sustainability. 2022;14(6):3667. doi: 10.3390/su14063667
  46. Fufa BK, Tadesse BA, Tulu MM. Cultivation of Pleurotus ostreatus on Agricultural Wastes and Their Combination. International Journal of Agronomy. 2021;1465597.
  47. Lesa KN, Khandaker MU, Iqbal FMR, Sharma R, Islam F, Mitra S, et al. Nutritional Value, Medicinal Importance, and Health-Promoting Effects of Dietary Mushroom (Pleurotus ostreatus). Journal of Food Quality. Volume 2022;2454180.
  48. Zhao Q, Liu X, Cui L, Ma C. Extraction and bioactivities of the chemical composition from Pleurotus ostreatus: a review. Journal of Future Foods. 2024;4(2):111-118.

Download Article
Received January 5, 2025.
Accepted February 11, 2025.
©2025 International Medical Research and Development Corporation.